Loughborough, United Kingdom

Bryan Glyn Roberts

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 5.4

ph-index = 2

Forward Citations = 28(Granted Patents)


Location History:

  • Leics., GB (2005)
  • Loughborough, GB (2003 - 2011)
  • Leicestershire, GB (2011)

Company Filing History:


Years Active: 2003-2011

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Bryan Glyn Roberts

Introduction: Bryan Glyn Roberts, an accomplished inventor based in Loughborough, GB, has made significant strides in the field of pharmaceuticals. With a remarkable portfolio of 8 patents, his work focuses on isoquinolinone derivatives that have promising applications in therapy.

Latest Patents: Among his latest innovations, Roberts has developed patents related to isoquinolinone derivatives. The compounds described in his patents include derivatives of formula (I), which are intended for pharmaceutical compositions and their therapeutic applications. These innovations aim to provide new avenues for treatment, highlighting the importance of ongoing research in pharmaceutical sciences.

Career Highlights: Throughout his career, Bryan Glyn Roberts has worked with prestigious companies such as AstraZeneca AB and AstraZeneca UK Limited. These experiences have undoubtedly provided him with valuable insights and resources to advance his research and inventions in the pharmaceutical industry.

Collaborations: Roberts has collaborated with esteemed individuals in his field, including Nicholas David Kindon and Andrew Baxter. These partnerships exemplify the collaborative nature of innovation, where sharing knowledge and expertise often leads to groundbreaking developments.

Conclusion: Bryan Glyn Roberts stands out as a significant figure in the realm of pharmaceuticals, with his patented inventions promising to advance therapeutic practices. His contributions, particularly in the area of isoquinolinone derivatives, reflect the importance of innovation in enhancing healthcare solutions. The collaborative efforts with notable colleagues further highlight the collective commitment to pushing the boundaries of science and medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…